SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

Topic 313 Phase I; RNAI Cancer Therapeutics Using Nanotechnology; HHSN2612013000
Award last edited on: 10/11/19

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$1,200,000
Award Phase
2
Solicitation Topic Code
313
Principal Investigator
Gretchen M Unger

Company Information

GeneSegues Inc

10285 Yellow Circle Drive
Minnetonka, MN 55343
   (612) 354-5753
   lb@genesegues.com
   www.genesegues.com
Location: Single
Congr. District: 03
County: Hennepin

Phase I

Contract Number: 261201300030C-0-0-1
Start Date: 9/20/13    Completed: 6/19/14
Phase I year
2013
Phase I Amount
$200,000
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.

Phase II

Contract Number: 261201300030C-7-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2014
Phase II Amount
$1,000,000
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.